Murcia, March 14, 2026
Daphne Lab® and Free Farma (distributor for Spain and Latin America) announce significant advancements in the development and global dissemination of innovative biofunctional tools, following their participation in the International Autism Congress 2026, held in Murcia.
The congress served as a key platform for international dialogue, fostering collaboration among scientific institutions, healthcare professionals, and industry stakeholders. It further reinforced a shared vision grounded in integrative medicine, prevention, and personalized therapeutic approaches for Autism Spectrum Disorders (ASD).
Participation and Key Outcomes
Representing Daphne Lab®, Free Farma attended the congress.
During the event, the latest advancements in biofunctional technologies were presented, with particular emphasis on the BioMetaTest® system, which is increasingly recognized as a valuable tool for supporting both professionals and families in the management of ASD.
The strong attendance and active engagement of participants—including clinicians, companies, and families—highlighted a growing demand for innovative models that integrate functional analysis, nutrition, and personalized care pathways.
This context also generated tangible opportunities for international expansion, particularly in strategic markets such as Portugal and Brazil, further strengthening the global positioning of the organizations involved.
Scientific Innovation: BioMetaTest®
At the core of this initiative is BioMetaTest®, a proprietary technology developed by Daphne Lab® within the framework of functional and integrative medicine. It is designed to:
- Assess metabolic and functional biomarkers
- Detect subclinical biochemical imbalances
- Support personalized nutritional and therapeutic interventions
By translating complex biomedical data into actionable clinical insights, BioMetaTest® contributes to the advancement of a preventive, predictive, and patient-centered healthcare model, while supporting the continuous pursuit of robust scientific evidence.
Vision and International Development
Daphne Lab® and Free Farma, share a forward-looking vision aimed at shaping a more advanced, human-centered, and accessible healthcare system, built on international cooperation and multidisciplinary integration.
Participation in the International Autism Congress 2026 further reinforced:
- The scientific and technological positioning of the organizations
- The development of international professional networks
- The advancement of innovative solutions for ASD management
- Expansion into high-potential global markets
Institutional Statements
Dr. Luigi Di Vaia, Founder of Daphne Lab®, stated:
“Our mission is to develop scientific tools that place the individual at the center of the therapeutic journey. The feedback received during this congress confirms that functional and integrative medicine represents a concrete and essential direction for the future of healthcare.”
Gabriel Pelaez, Commercial Director of Free Farma, added:
“Our participation in this congress reinforces our commitment to driving innovation, education, and practical solutions for both professionals and families. We are building an increasingly strong international network between Europe and Latin America.”
Conclusion
The collaboration between Daphne Lab® and Free Farma marks a significant step toward a new paradigm in healthcare—one that is more preventive, personalized, and integrated.
Guided by the principle:
“Science, innovation, and human commitment in the service of health”, the organizations continue to advance their mission, with the goal of delivering effective, accessible, and high-impact solutions for both patients and professionals worldwide.
Press Contacts
Daphne Lab®
www.daphnelab.com
Massimo Casanova – Commercial Manager
export@daphnelab.com
WhatsApp: +39 389 0591308
Free Farma (Spain & LATAM)
www.freefarma.es
Gabriel Pelaez – Commercial Director
gabriel@freefarma.es